Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari

▼REZZAYO® (rezafungin) click for GB prescribing information or NI prescribing information

Expert presentations and opinions on Invasive candidiasis

Watch or listen to expert presentations and opinions on invasive candidiasis access dedicated learning resources or materials for your patients

To access efficacy, safety & tolerability of ▼REZZAYO® (rezafungin) as well as efficacy data please click here.

    Adverse events should be reported. Reporting forms and information can be found at

    Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or